Clinical Trials Logo

Filter by:
NCT ID: NCT06000306 Completed - Clinical trials for Measurable Residual Disease

MRD Monitoring by Digital Droplet PCR in the Early Period After Allo-HSCT to Predict Patients at High Risk of Relapse

Start date: January 1, 2018
Phase:
Study type: Observational

A study on the Effectiveness of digital droplet PCR in monitoring measurable residual disease during the early period after allogeneic hematopoietic stem cell transplantation to predict patients at high risk of relapse

NCT ID: NCT06000241 Completed - Bowel Preparation Clinical Trials

Comparison of Same Morning vs Previous Evening Dosing Regimen for Assessment of Quality of Bowel Preparation for Colonoscopy Under Anesthesia

Start date: January 1, 2021
Phase:
Study type: Observational

220 patients are allocated randomly to the morning group (am group) or the afternoon group (pm group) and assessed by quality of bowel preparation and residual volume gastric residue.

NCT ID: NCT06000137 Completed - Clinical trials for Patient-controlled Analgesia

The Comparison of the Analgesic Effects of Dezocine and Sufentanil in Patient-controlled Analgesia After Laryngectomy

Start date: February 10, 2022
Phase: N/A
Study type: Interventional

Laryngeal cancer is one of the most common tumors in otolaryngology. In China, it accounts for 1-5% of all malignancies and has an incidence of 1.13 per 100,000. Surgical resection is the most important treatment for patients who are not candidates for chemoradiotherapy or refuse chemoradiotherapy. The types of surgery include total and partial laryngectomy. Patients with laryngeal cancer often face multiple physical and psychiatric changes after surgery, such as daily large sputum production accompanied by cough, cleaning care of the air incision, fatigue, and sleep disturbances. Some patients do not actively exclude secretions due to pain, and the formation of sputum plugs causes lung inflammation, which is not conducive to postoperative recovery. Good postoperative pain management is beneficial to shorten the length of hospital stay and reduce mortality. Sufentanil is most commonly used for postoperative analgesia and has good analgesic effect, but there are some adverse effects, such as dizziness, nausea and vomiting, urinary retention, skin itching, respiratory depression, etc. As a new type of analgesic, dezocine has been widely used in clinical practice with few adverse reactions to the respiratory and circulatory system, and its application to postoperative analgesia can significantly improve the immune activity. At present, there are not many studies on continuous analgesia of dezocine, mostly single-dose analgesia studies, this study for different doses of dezocine for the postoperative analgesic effect of laryngeal cancer patients, compared with the current classic opioid analgesics, to provide a new scheme for clinical medication.

NCT ID: NCT05999682 Completed - Sepsis Clinical Trials

Improvement of Organ Function by Apigenin in Elderly Patients With Sepsis

Start date: September 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

In this single-center, randomized, single-blind, placebo-controlled pilot clinical trial. The effect of apigenin on the improvement of organ function will be investigated in elderly patients with sepsis. Researchers will screen patients admitted to the Department of Critical Care Medicine at Zhujiang Hospital to identify patients with sepsis based on including and excluding criteria and obtain informed consent and randomize them into groups. The treatment group will be given apigenin tablets 50mg ground with 5ml of sterilized water for intra-gastric tube injection; the control group will be given an equal volume of sterilized water for intra-gastric tube injection. The changes in SOFA score and other clinically meaningful outcomes in 4 days will be collected.

NCT ID: NCT05999058 Completed - Clinical trials for Lacrimal Duct Obstruction

Clinical Study of Lacrimal Drainage Obstruction Diseases Using Dacryoendoscopy

Start date: November 1, 2019
Phase: N/A
Study type: Interventional

Nasolacrimal duct obstruction (NLDO) can manifest as epiphora or recurrent infections with mucopurulent discharge and may even cause social embarrassment. Dacryoendoscopic-assisted laser dacryoplasty with silicone intubation (DLDI) offers direct therapy to the obstructed site, leading to minimal collateral damage external to the target zone. Although the silicone intubation using dacryoendoscopy has increased the success rates, the success rates vary from a low of 51% to a high of 90%. The difference in success rates seems to depend on the site of obstruction, differences in the surgical technique, stringency of definitions of success, and duration of follow-up. The aim of our study was to report the results of DLDI for the management of NLDO, and to identify factors associated with DLDI failure.

NCT ID: NCT05998421 Completed - Acupuncture Clinical Trials

The Effects of Acupuncture on the Natural Pregnancy in Patients With Recurrent Abortion

Start date: March 1, 2022
Phase: N/A
Study type: Interventional

Recurrent spontaneous abortion (RSA) is a common pregnancy complication in women of reproductive age and the cause of RSA remains largely unclear. Acupuncture is widely used in clinical practice to treat infertility and abortion. The role of acupuncture in the treatment of infertility is still unclear. The investigators conducted a randomized, prospective, controlled clinical trial to investigate its potential impact on pregnancy outcome. Herein, the investigators not only evaluated the changes in patients' psychological stress before and after treatment but also followed up on pregnancy outcomes. In addition, changes in uterine artery blood flow were observed by ultrasound. Changes in coagulation-related indicators were also detected.

NCT ID: NCT05998304 Completed - Clinical trials for Healthy Male Subjects

ADME Study of [14C] Yiqibuvir in Healthy Male Subjects

Start date: August 7, 2023
Phase: Phase 1
Study type: Interventional

This is a single-centre, open-label, mass balance and biotransformation study in healthy male subjects utilising a single oral dose of [14C] Yiqibuvir.

NCT ID: NCT05998252 Completed - Clinical trials for Coronary Artery Disease

Evaluate Safety and Efficacy of Alveo HP Balloon Dilatation Catheter for Balloon Dilatation of Coronary Artery Stenosis

Start date: December 27, 2022
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, single-group study aims to evaluate the safety and efficacy of Alveo HP Balloon Dilatation Catheter for balloon dilatation of coronary artery stenosis. Pre-dilation with Alveo balloon dilatation catheter followed by conventional PCI, and follow-up will be carried out. During the trial, the enrollment, treatment and follow-up of the subjects will be recorded, and the safety and efficacy of the investigational device will be evaluated.

NCT ID: NCT05997238 Completed - Clinical trials for Osteoarthritis, Knee

Evaluation of the Effect of Triamcinolone at Different Doses on LIA During TKA

LIA;TKA
Start date: April 25, 2023
Phase: Phase 4
Study type: Interventional

To evaluate the efficacy and safety of different doses of triamcinolone for local infiltration analgesia during total knee replacement

NCT ID: NCT05996978 Completed - Ischemic Stroke Clinical Trials

Intensive Drug Therapy for Ischemic Stroke Caused by Severe Intracranial Arterial Stenosis

Start date: February 1, 2020
Phase:
Study type: Observational

To observe the safety and efficacy of intensive drug therapy for ischemic stroke caused by severe intracranial arterial stenosis.Patients with acute stroke caused by intracranial arterial stenosis (stenosis rate ≥70%) were enrolled and accept dual antiplatelet therapy (DAPT) (aspirin 100 mg/d and clopidogrel 75 mg/d for 90 days, followed by aspirin 100 mg/d for long term) under the guidance of platelet function analysis (Verifynow) combined with the intensive statin therapy (40 mg/d for 14 days, followed by 20 mg/d for long term).